OR52I1 inhibitors represent a class of chemical compounds that specifically interact with and modulate the activity of the olfactory receptor OR52I1, a member of the G protein-coupled receptor (GPCR) superfamily. Olfactory receptors, including OR52I1, are predominantly involved in the detection of volatile compounds, playing a critical role in the sense of smell by binding specific odorant molecules. The OR52I1 receptor, like other GPCRs, initiates intracellular signaling pathways by coupling to G proteins upon activation. The mechanism of inhibition for these compounds typically involves preventing the binding of odorant molecules to the receptor, or hindering the subsequent conformational changes necessary for G protein activation. Through this inhibition, OR52I1 inhibitors can affect the signal transduction processes associated with olfactory perception.
Structurally, OR52I1 inhibitors can vary significantly, often containing chemical groups designed to mimic the natural odorant ligands of the receptor. These molecules are engineered to fit into the binding pocket of OR52I1, blocking or altering its activity without necessarily activating the receptor. The specificity and binding affinity of these inhibitors are critical factors influencing their effectiveness. The molecular interactions between the inhibitor and the receptor typically involve hydrophobic contacts, hydrogen bonding, and van der Waals forces. Research into these inhibitors also sheds light on the broader functional understanding of GPCR signaling and ligand-receptor dynamics. This class of compounds provides important tools for studying the intricate molecular mechanisms governing olfactory signal transduction, offering insights into receptor biology and the chemical diversity of olfaction.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid could downregulate OR52I1 expression by binding to retinoic acid receptors that interact with the OR52I1 gene promoter, inhibiting its transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
This polyphenolic compound could reduce the expression of the OR52I1 gene by inhibiting NF-κB signaling, which may be involved in the transcriptional activation of the OR52I1 gene. | ||||||